These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18937189)

  • 1. Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient.
    Höblinger A; Tiemann K; Nickenig G; Sauerbruch T; Lammert F
    Z Gastroenterol; 2008 Oct; 46(10):1194-7. PubMed ID: 18937189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Kuhn H
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
    J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
    Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
    Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
    Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
    Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
    Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation.
    Paramesh AS; Fairchild RB; Quinn TM; Leya F; George M; Van Thiel DH
    Liver Transpl; 2005 Feb; 11(2):236-8. PubMed ID: 15666373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites.
    Allard JP; Chau J; Sandokji K; Blendis LM; Wong F
    Am J Gastroenterol; 2001 Aug; 96(8):2442-7. PubMed ID: 11513188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
    Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy.
    Jiang TY; Wu XS; Lu Q; Meng X; Jia CQ; Zhang Y
    Chin Med J (Engl); 2004 Feb; 117(2):296-8. PubMed ID: 14975219
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
    Kavitt RT; Yang VL; Jensen DM
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of hypertrophic obstructive cardiomyopathy complicated by a single coronary artery treated by transcoronary septal ablation.
    Hara H; Ishii K; Nakamura M
    J Invasive Cardiol; 2006 May; 18(5):234-8. PubMed ID: 16670451
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic obstructive cardiomyopathy in liver transplant patients.
    Hage FG; Bravo PE; Zoghbi GJ; Bynon JS; Aqel RA
    Cardiol J; 2008; 15(1):74-9. PubMed ID: 18651389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.